David Wu MD in Royal Oak, Michigan

Home Michigan Royal Oak

David Wu MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 30701 Woodward Ave in Royal Oak, Michigan.

They're a part of the: Greenberger Wu Dunn And Fields Pllc medical group which has around 4 members. You can call their office at 248-548-2114 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Michigan Medical School and graduated in 1990 (around 34 years of experience). They are listed as doing telehealth appointments.

David M H Wu MD Office Phone and Directions

David Wu MD
Greenberger Wu Dunn And Fields Pllc
30701 Woodward Ave
Royal Oak, Michigan 48073
248-548-2114

Patient Ratings
Please rate your experience with David Wu MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 248-548-2114

Enter a starting address:

Healthcare Info for David Wu MD

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: University Of Michigan Medical School
Graduation Year: 1990
The Primary Medical Specialty for David Wu MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 34
PAC (PECOS ID)#: 9931139706
NPI #: 1740236652
NPI Created On: 05/25/2006
NPI Last Updated Listed as: 10/10/2023
Primary Taxonomy Code: 207RP1001X
License Number:
DA056631
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Molina Healthcare of Michigan, Inc.
Humana
Total Health Care USA, Inc.
McLaren Health Plan Community
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Cantonese, Mandarin, Chinese.

Services and Procedures include:

Removal of fluid from chest cavity with imaging guidance
Ultrasound of chest
Measurement and graphic recording of total and timed exhaled air capacity
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Determination of lung volumes using gas dilution or washout
Measurement of lung diffusing capacity
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Hospital observation care, typically 70 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788626847

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801602975

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801605117

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801606765

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801908627

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801940485

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802069369

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802254399

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802399401

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802407847

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Pulmonary Disease Professionals in Royal Oak

1.
Muhammad Alam

3601 W 13 Mile Rd Bcc
Royal-oak, MI
Beaumont Medical Group- Specialty Services

2.
Muhammad Alam

3601 W 13 Mile Rd Ec
Royal-oak, MI
Beaumont Medical Group- Specialty Services

3.
Muhammad Alam

3601 W 13 Mile Rd 2 S Fetal Imaging
Royal-oak, MI
Beaumont Medical Group- Specialty Services

4.
Muhammad Alam

3601 W 13 Mile Rd
Royal-oak, MI
Beaumont Medical Group- Specialty Services

5.
Daniel Keena MD

3571 W 13 Mile Rd Fl
Royal-oak, MI
Beaumont Medical Group- Specialty Services

6.
Daniel Keena MD

3581 W 13 Mile Rd Bcc
Royal-oak, MI
Beaumont Medical Group- Specialty Services

Providers in Greenberger Wu Dunn And Fields Pllc

1.Marc Dunn Md

30701 Woodward Ave
Royal Oak Mi 48073-0990
Greenberger Wu Dunn And Fields Pllc
Pulmonary Disease

2.Warren Fields

30701 Woodward Ave
Royal Oak Mi 48073-0990
Greenberger Wu Dunn And Fields Pllc
Pulmonary Disease

3.Marc Greenberger Md

30701 Woodward Ave
Royal Oak Mi 48073-0990
Greenberger Wu Dunn And Fields Pllc
Pulmonary Disease

4.David Wu Md

30701 Woodward Ave
Royal Oak Mi 48073-0990
Greenberger Wu Dunn And Fields Pllc
Pulmonary Disease

View all 4 members of Greenberger Wu Dunn And Fields Pllc medical group